FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileCerenome, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CNSY
Cerenome, Inc. Stock AnalysisComprehensive stock analysis for Cerenome, Inc. (CNSY) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCNSY
CNSY
Cerenome, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CNSY
  1. Home
  2. Stocks
  3. Cerenome, Inc.
CN

Cerenome, Inc.

🇺🇸CNSY•NASDAQ
CN

Cerenome, Inc.

🇺🇸CNSY•NASDAQ
Market cap
$6.16M

Your view on CNSY

Mkt Cap
$6.16M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Cerenome, Inc.

Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Marc H. Hedrick
Headquarters
Houston, TX, US
Industry
Medical - Pharmaceuticals
Sector
Healthcare
CEO
Marc H. Hedrick
Headquarters
Houston, TX, US
Description

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J.

Calhoun in July 1996 and is headquartered in Houston, TX.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Cerenome, Inc.. Starting points for Cerenome, Inc.: EPS -$4.01, beta 1.49 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Cerenome, Inc.. Trailing twelve-month EPS for Cerenome, Inc. stands at -$4.01. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Cerenome, Inc.. Cerenome, Inc. has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold CNSY12 companies
More Medical - Pharmaceuticals companies
TickerTypeCompanySectorExchangeMkt cap
AIBTAibotics Inc.HealthcareOTC$484,674
AJOYAyujoy Herbals Ltd.HealthcareOTC$103,731
AJYGAJ1G, Inc.HealthcareOTC$928,056
ALSTAllstar Health Brands, Inc.HealthcareOTC$6,759
AOXGAoxing Pharmaceutical Company, Inc.HealthcareOTC$381,080
AREVFAREV Life Sciences Global Corp.HealthcareOTC$15,881
ATTBFAbattis Bioceuticals Corp.HealthcareOTC—
BDPTBioAdaptives, Inc.HealthcareOTC$197,978
BFRIBiofrontera Inc.HealthcareNASDAQ$7.9M
BFRIWBiofrontera Inc.HealthcareNASDAQ$796,653
BGMSBio Green Med Solution, Inc.HealthcareNASDAQ$3.1M
BGXXQBright Green CorporationHealthcarePNK—
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Cerenome, Inc., and how their positions are changing. At a $6.2M market value, institutional positions materially move Cerenome, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Cerenome, Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Cerenome, Inc.. Coverage tracks Cerenome, Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Cerenome, Inc.

CNSY AnalysisWeak
Past
1
Growth
1
Health
1
Profit
1
Value
1